Edwards Lifesciences Corp is 2.9x more valuable than ZIMMER BIOMET HOLDINGS, INC. by market capitalization ($49.51 B vs $17.06 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZBH | EW |
|---|---|---|
| Market cap | $17.06 B | $49.51 B |
| US-listed rank | #677 | #320 |
| Revenue (latest FY) | $8.23B | $6.07B |
| Net income (latest FY) | $705.10M | $1.07B |
| Net margin | 8.6% | 17.7% |
| P/E (trailing FY) | 24.2 | 46.1 |
| SEC filings | 1,000 | 2,569 |
Edwards Lifesciences Corp is 2.9x more valuable than ZIMMER BIOMET HOLDINGS, INC. by market capitalization ($49.51 B vs $17.06 B).
In their latest fiscal years, ZIMMER BIOMET HOLDINGS, INC. reported $8.23B in revenue while Edwards Lifesciences Corp reported $6.07B.
Full pages: ZIMMER BIOMET HOLDINGS, INC. and Edwards Lifesciences Corp, or browse the full rankings.